Professional Statements and Societal Positions Guidelines
The Endocrine Society
The Endocrine Society recommends screening for vitamin D deficiency in individuals at risk for deficiency. The society does not recommend population screening for vitamin D deficiency in individuals who are not at risk. It is recommended using the serum circulating 25-hydroxyvitamin D [25(OH)D] level, measured by a reliable assay to evaluate Vitamin D status in patients who are at risk for vitamin D deficiency. The society recommends using the serum 1,25-dihydroxyvitamin D [1,25(OH)2D] assay in monitoring certain conditions, such as acquired and inherited disorders of vitamin D and phosphate metabolism.
American Society for Clinical Pathology and Choosing Wisely
American Society for Clinical Pathology and Choosing Wisely recommends not performing population based screening for 25-OH-Vitanin D deficiency.Vitamin D deficiency is common in many populations, particularly in patients at higher latitudes, during winter months and in those with limited sun exposure. Over the counter Vitamin D supplements and increased summer sun exposure are sufficient for most otherwise healthy patients. Laboratory testing is appropriate in higher risk patients when results will be used to institute more aggressive therapy (e.g., osteoporosis, chronic kidney disease, malabsorption, some infections, obese individuals).
U.S. Preventive Services Task Force (USPSTF)
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for vitamin D deficiency in asymptomatic adults.